Enzon Pharmaceuticals (ENZN) Short Interest Ratio & Short Volume $0.11 +0.00 (+1.95%) As of 11:48 AM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsSEC FilingsShort InterestBuy This Stock Enzon Pharmaceuticals Short Interest DataEnzon Pharmaceuticals (ENZN) has a short interest of 3,500 shares, representing 0.00% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 66,088 shares to cover all short positions.Current Short Interest3,500 sharesPrevious Short Interest3,500 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$287.00Short Interest Ratio0.4 Days to CoverLast Record DateJune 15, 2025Outstanding Shares74,210,000 sharesShort Percent of Float0.00%Today's Trading Volume18,226 sharesAverage Trading Volume66,088 sharesToday's Volume Vs. Average28% Short Selling Enzon Pharmaceuticals? Sign up to receive the latest short interest report for Enzon Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartENZN Short Interest Over TimeENZN Days to Cover Over TimeENZN Percentage of Float Shorted Over Time Enzon Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/20253,500 shares $287.00 No Change0.0%0.4 $0.08 5/31/20253,500 shares $301.00 No Change0.0%0.1 $0.09 5/15/20253,500 shares $288.75 No Change0.0%0.2 $0.08 4/30/20253,500 shares $315.00 No ChangeN/A0.3 $0.09 4/15/20253,500 shares $331.10 -82.8%0.0%0.1 $0.09 3/31/202520,300 shares $2.09 thousand +217.2%0.0%0.4 $0.10 3/15/20256,400 shares $646.40 -12.3%0.0%0.1 $0.10 2/28/20257,300 shares $803.00 +55.3%0.0%0 $0.11 2/15/20254,700 shares $632.62 -91.5%0.0%0.1 $0.13 1/31/202555,100 shares $8.24 thousand +2,523.8%N/A0.3 $0.15 Get the Latest News and Ratings for ENZN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enzon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20252,100 shares $301.56 -74.1%N/A0 $0.14 12/31/20248,100 shares $1.26 thousand +406.3%N/A0 $0.16 12/15/20241,600 shares $182.00 No ChangeN/A0 $0.11 11/30/20241,600 shares $128.00 No ChangeN/A0 $0.08 11/15/20241,600 shares $131.20 -40.7%N/A0.1 $0.08 10/31/20242,700 shares $243.00 +68.8%N/A0 $0.09 10/15/20241,600 shares $187.52 No ChangeN/A0.1 $0.12 9/30/20241,600 shares $224.00 -33.3%N/A0.1 $0.14 9/15/20242,400 shares $302.54 +50.0%N/A0 $0.13 8/31/20241,600 shares $232.96 No ChangeN/A0.1 $0.15 8/15/20241,600 shares $256.32 -64.4%N/A0 $0.16 7/31/20244,500 shares $675.00 -61.2%N/A0.3 $0.15 7/15/202411,600 shares $1.79 thousand -37.0%N/A0.8 $0.15 6/30/202418,400 shares $3.31 thousand -3.7%N/A0.7 $0.18 6/15/202419,100 shares $2.68 thousand -28.5%N/A0.1 $0.14 5/31/202426,700 shares $3.47 thousand +1,568.8%N/A0.2 $0.13 5/15/20241,600 shares $144.00 No ChangeN/A0 $0.09 4/30/20241,600 shares $133.52 -87.6%N/A1.5 $0.08 4/15/202412,900 shares $964.92 +239.5%N/A0.6 $0.07 3/31/20243,800 shares $359.10 +137.5%N/A0.1 $0.09 3/15/20241,600 shares $132.48 -73.3%N/A0 $0.08 2/29/20246,000 shares $393.00 +275.0%N/A0.3 $0.07 2/15/20241,600 shares $144.00 -20.0%N/A0.1 $0.09 1/15/20241,600 shares $142.08 No ChangeN/A0.1 $0.09 12/31/20231,600 shares $149.68 -42.9%N/A0 $0.09 12/15/20232,800 shares $288.40 -58.2%N/A0.1 $0.10 11/30/20236,700 shares $703.50 +318.8%N/A0.1 $0.11 11/15/20231,600 shares $224.00 No ChangeN/A0.3 $0.14 10/31/20231,600 shares $240.00 No ChangeN/A0.1 $0.15 10/15/20231,600 shares $221.12 No ChangeN/A0.1 $0.14A new rule goes live in July — and the banks are quietly cashing in (Ad)A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how 9/30/20231,600 shares $234.68 -76.8%N/A0.2 $0.15 9/15/20236,900 shares $938.40 -42.0%N/A0.3 $0.14 8/31/202311,900 shares $1.84 thousand +643.8%N/A0.7 $0.16 8/15/20231,600 shares $240.00 -27.3%N/A0.1 $0.15 7/31/20232,200 shares $440.00 No ChangeN/A0.3 $0.20 7/15/20232,200 shares $440.00 -57.7%N/A0.2 $0.20 6/30/20235,200 shares $1.04 thousand +136.4%N/A0.1 $0.20 6/15/20232,200 shares $310.20 -33.3%N/A0.1 $0.14 5/31/20233,300 shares $445.50 +106.3%N/A0.1 $0.14 5/15/20231,600 shares $251.20 No ChangeN/A0 $0.16 4/30/20231,600 shares $328.00 -33.3%N/A0.2 $0.21 4/15/20232,400 shares $494.40 -7.7%N/A0.1 $0.21 3/31/20232,600 shares $676.00 -75.5%N/A0.1 $0.26 3/15/202310,600 shares $2.65 thousand +523.5%N/A0.5 $0.25 2/28/20231,700 shares $433.50 -81.1%N/A0 $0.26 2/15/20239,000 shares $2.48 thousand +350.0%N/A0.7 $0.28 1/31/20232,000 shares $530.00 -85.2%N/A0.2 $0.27 1/15/202313,500 shares $3.51 thousand -27.0%N/A0.2 $0.26 12/30/202218,500 shares $4.56 thousand No ChangeN/A0.4 $0.25 12/15/202218,500 shares $4.84 thousand +1,056.3%N/A0.5 $0.26 11/30/20221,600 shares $439.68 -92.1%N/A0.1 $0.27 11/15/202220,200 shares $5.45 thousand +910.0%N/A0.3 $0.27 10/31/20222,000 shares $580.00 -73.3%N/A0 $0.29 10/15/20227,500 shares $2.10 thousand -7.4%N/A0.5 $0.28 9/30/20228,100 shares $2.29 thousand +268.2%N/A0.1 $0.28 9/15/20222,200 shares $679.36 -66.2%N/A0.1 $0.31 8/31/20226,500 shares $1.77 thousand +140.7%N/A0 $0.27 8/15/20222,700 shares $1.08 thousand -54.2%N/A0 $0.40 7/31/20225,900 shares $1.98 thousand +247.1%N/A0.2 $0.34 7/15/20221,700 shares $501.50 -95.2%N/A0 $0.30 6/30/202235,200 shares $10.74 thousand +2,100.0%N/A0.3 $0.31 6/15/20221,600 shares $448.00 -5.9%N/A0 $0.28 5/31/20221,700 shares $518.50 -56.4%N/A0.1 $0.31 5/15/20223,900 shares $1.15 thousand -81.7%N/A0.1 $0.30 4/30/202221,300 shares $6.71 thousand +191.8%N/A0.2 $0.32 4/15/20227,300 shares $2.57 thousand +265.0%N/A0.1 $0.35 3/31/20222,000 shares $604.80 -35.5%N/A0.1 $0.30 3/15/20223,100 shares $931.55 +24.0%N/A0.1 $0.30 2/28/20222,500 shares $800.00 -30.6%N/A0.1 $0.32 2/15/20223,600 shares $1.31 thousand +125.0%N/A0 $0.36 1/31/20221,600 shares $656.00 -81.4%N/A0 $0.41 1/15/20228,600 shares $3.05 thousand +437.5%N/A0.2 $0.36 12/31/20211,600 shares $548.00 No ChangeN/A0 $0.34 12/15/20211,600 shares $528.00 -76.5%N/A0 $0.33 11/30/20216,800 shares $2.51 thousand -53.7%N/A0 $0.37 11/15/202114,700 shares $5.14 thousand +818.8%N/A0.1 $0.35 10/29/20211,600 shares $511.52 -40.7%N/A0 $0.32 10/15/20212,700 shares $915.30 -30.8%N/A0.1 $0.34 9/30/20213,900 shares $1.47 thousand -48.7%N/A0 $0.38 9/15/20217,600 shares $2.75 thousand -12.6%N/A0.1 $0.36A new rule goes live in July — and the banks are quietly cashing in (Ad)A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how 8/31/20218,700 shares $2.87 thousand +8.8%N/A0.1 $0.33 8/13/20218,000 shares $3.28 thousand -16.7%N/A0 $0.41 7/30/20219,600 shares $5.18 thousand +15.7%N/A0.1 $0.54 7/15/20218,300 shares $5.44 thousand +196.4%N/A0.1 $0.66 6/30/20212,800 shares $1.85 thousand -60.0%N/A0 $0.66 6/15/20217,000 shares $5.17 thousand -7.9%N/A0.1 $0.74 5/28/20217,600 shares $4.41 thousand +31.0%N/A0.1 $0.58 5/14/20215,800 shares $3.22 thousand -34.8%N/A0.1 $0.56 4/30/20218,900 shares $5.34 thousand +178.1%N/A0.1 $0.60 4/15/20213,200 shares $2.30 thousand -76.8%N/A0 $0.72 3/31/202113,800 shares $10.56 thousand +762.5%N/A0.1 $0.76 3/15/20211,600 shares $1.01 thousand -76.5%N/A0 $0.63 2/26/20216,800 shares $4.18 thousand +161.5%N/A0 $0.61 2/12/20212,600 shares $1.57 thousand -94.1%N/A0 $0.60 1/29/202144,400 shares $19.54 thousand +21.6%N/A0.1 $0.44 1/15/202143,700 shares $13.77 thousand +241.4%N/A0.1 $0.32 12/31/202024,500 shares $6.59 thousand -43.9%N/A0.1 $0.27 12/15/202043,700 shares $10.93 thousand +241.4%N/A0.1 $0.25 11/30/202012,800 shares $2.33 thousand -36.6%N/A0.1 $0.18 11/15/202020,200 shares $3.05 thousand +5.8%N/A0.2 $0.15 10/30/202019,100 shares $2.78 thousand +135.8%N/A0.2 $0.15 10/15/20208,100 shares $1.30 thousand +88.4%N/A0 $0.16 9/30/20204,300 shares $796.36 -62.0%N/A0.1 $0.19 9/15/202011,300 shares $1.99 thousand -29.8%N/A0.1 $0.18 8/31/202016,100 shares $3.05 thousand -53.9%N/A0.1 $0.19 8/14/202034,900 shares $7.50 thousand +122.3%N/A0.1 $0.22 7/31/202015,700 shares $3.14 thousand -38.2%N/A0.3 $0.20 7/15/202025,400 shares $4.14 thousand +103.2%N/A0.8 $0.16 ENZN Short Interest - Frequently Asked Questions What is Enzon Pharmaceuticals' current short interest? Short interest is the volume of Enzon Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of June 15th, traders have sold 3,500 shares of ENZN short. 0.00% of Enzon Pharmaceuticals' shares are currently sold short. Learn More on Enzon Pharmaceuticals' current short interest. What is a good short interest percentage for Enzon Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Enzon Pharmaceuticals' floating shares are currently sold short. How does Enzon Pharmaceuticals' short interest compare to its competitors? 0.00% of Enzon Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Enzon Pharmaceuticals: Curis, Inc. (1.24%), SAB Biotherapeutics, Inc. (0.45%), Bolt Biotherapeutics, Inc. (1.83%), Molecular Templates, Inc. (0.09%), Amgen Inc. (2.47%), Gilead Sciences, Inc. (1.85%), Vertex Pharmaceuticals Incorporated (1.57%), Regeneron Pharmaceuticals, Inc. (1.95%), Alnylam Pharmaceuticals, Inc. (2.63%), Biogen Inc. (2.32%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Enzon Pharmaceuticals stock? Short selling ENZN is an investing strategy that aims to generate trading profit from Enzon Pharmaceuticals as its price is falling. ENZN shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Enzon Pharmaceuticals? A short squeeze for Enzon Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ENZN, which in turn drives the price of the stock up even further. How often is Enzon Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENZN, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies CRIS Short Squeeze SABS Short Squeeze BOLT Short Squeeze MTEM Short Squeeze AFFY Short Squeeze AMGN Short Squeeze GILD Short Squeeze VRTX Short Squeeze REGN Short Squeeze ALNY Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ENZN) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enzon Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enzon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ENZN Stock Alerts